How do peptide and dietary supplement manufacturers set up cGMP 21 CFR Part 111 Certificate of Analysis (CoA) release in Odoo?

Steps

1. Enable lot tracking and incoming quality.control on raw material product categories; default receipts to quarantine stock.location.
2. On receipt validation, require supplier lot, CoA ir.attachment, and identity/purity/potency fields on quality.check before transfer to released raw stock.
3. Model blend or encapsulation as mrp.bom with component lots reserved on stock.move.line; capture weigh-and-dispense tare on work orders.
4. Attach in-process and finished-product CoA from third-party labs to finished stock.lot; block delivery pickings until quality state is pass.
5. Map allergen, gluten-free, or peptide potency attributes on product.template for label claim checks against BOM.
6. Configure mail.thread on quality.check and lot release groups for 21 CFR Part 11 style sign-off where validated.
7. Run annual FDA audit drill: export lot genealogy from raw CoA to finished shipment in one traceability report.

Common mistakes

• Receiving to production stock without CoA attachment on stock.lot.
• Using product-level CoA instead of lot-level documents when suppliers rotate lots weekly.
• Releasing finished goods on visual inspection only for peptide APIs requiring potency specs.
• Mixing R&D and commercial lots under one lot naming scheme.
• Deleting failed quality.check records instead of documenting deviations.

Odoo version notes

Supplement cGMP in Odoo 16–18 uses Enterprise Quality and MRP; peptides may need custom potency calculations on move lines. Part 111 is dietary supplement GMP—do not confuse with 21 CFR Part 210/211 drug GMP without validation scope. The ERP Firm ships CoA release workflows with upgrade-safe Git modules.

When to bring in help

If the fix touches custom modules, regulated traceability, or production outages, a focused rescue sprint beats months of trial and error. See our Odoo service.

See our industry practice